RSV Vaccine Warning
Summary The FDA mandates Guillain-Barré Syndrome warnings for RSV vaccines Abrysvo and Arexvy. Post-marketing data revealed a potential increased risk of GBS within 42 days of vaccination, though a causal link remains unestablished. The FDA […]
